Phase I-II Study of Radiopeptide 177 Lu-Octreotate in Combination with Capecitabine and Temozolomide in Advanced Low-Grade Neuroendocrine Tumors
Year: 2012
Type: article
Study design: Clinical Trial
Authors: Phillip G. Claringbold, Richard A. Price, J. Harvey Turner
Institutions: The University of Western Australia, Fremantle Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: capecitabine, temozolomide, low-grade neuroendocrine tumor, gastroenteropancreatic neuroendocrine tumors, peptide receptor radionuclide therapy, combination chemotherapy, treatment toxicity, progression-free survival, overall survival, objective response rate, dose escalation, thrombocytopenia, neutropenia
Open Access status: closed
OpenAlex ID: W2012856564
